• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[重组人促红细胞生成素治疗颗粒淋巴细胞增殖性疾病所致贫血的成功应用]

[The successful use of recombinant human erythropoietin therapy to anemia of granular lymphocyte proliferative disorder].

作者信息

Suzuki A, Aizawa S, Iwase O, Kuriyama K, Nagasu M, Kawanishi Y, Yaguchi M, Nehashi Y, Nakano M, Yoshikawa O

机构信息

First Department of Internal Medicine, Tokyo Medical College.

出版信息

Rinsho Ketsueki. 1995 Oct;36(10):1193-8.

PMID:8531330
Abstract

A 54-year-old man was admitted with fatigue. The peripheral blood count showed leukocytosis (9, 600/microliters), including 76% granular lymphocytes (GLs), which expressed CD2, 3, 8, 16 and HLA-DR, and anemia (hemoglobin 8.1 g/dl). He was diagnosed as having T cell type-granular lymphocyte proliferative disorder with anemia. Bone marrow examination revealed the involvement of 4.6% of GL and erythroblastopenia. A clonogenic assay of bone marrow cells revealed the decrease in erythroid colony formation in both CFU-E and BFU-E, but the number of erythroid colonies increased when CD8-positive cells were depleted from bone marrow cells and the number of erythroid colonies decreased again when CD8-positive GLs were added. The supernatant of cultured CD8-positive GLs had no inhibitory effect on CFU-E and BFU-E colony formation. These suggested that CD8-positive GLs suppressed the erythroid colony formation in this case. Treatment with 6,000 U/body of recombinant human erythropoietin (rh-Epo) subcutaneously three times a week was started and increased dose of 12,000 U/body of rh-Epo led to an increase in the hemoglobin level to 10.5 g/dl two months later. He has been treated with rh-Epo only.

摘要

一名54岁男性因疲劳入院。外周血细胞计数显示白细胞增多(9600/微升),其中包括76%的颗粒淋巴细胞(GLs),这些细胞表达CD2、3、8、16和HLA - DR,同时伴有贫血(血红蛋白8.1克/分升)。他被诊断为患有伴贫血的T细胞型颗粒淋巴细胞增殖性疾病。骨髓检查显示4.6%的GL受累且有红细胞生成减少。骨髓细胞克隆形成试验显示CFU - E和BFU - E中的红系集落形成均减少,但当从骨髓细胞中去除CD8阳性细胞时红系集落数量增加,而当加入CD8阳性GLs时红系集落数量再次减少。培养的CD8阳性GLs的上清液对CFU - E和BFU - E集落形成无抑制作用。这些提示在该病例中CD8阳性GLs抑制了红系集落形成。开始每周三次皮下注射6000单位/体的重组人促红细胞生成素(rh - Epo),将rh - Epo剂量增加至12000单位/体后,两个月后血红蛋白水平升至10.5克/分升。他一直仅接受rh - Epo治疗。

相似文献

1
[The successful use of recombinant human erythropoietin therapy to anemia of granular lymphocyte proliferative disorder].[重组人促红细胞生成素治疗颗粒淋巴细胞增殖性疾病所致贫血的成功应用]
Rinsho Ketsueki. 1995 Oct;36(10):1193-8.
2
In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.重组人促红细胞生成素对慢性肾衰竭患者骨髓造血的体内效应。
Eur J Med Res. 1998 Dec 16;3(12):564-70.
3
Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.血液透析中重组人促红细胞生成素抵抗。配对滤过透析的作用。
ASAIO J. 1997 Sep-Oct;43(5):M535-8.
4
Responsiveness to recombinant human erythropoietin (rh-Epo) of marrow erythroid progenitors (CFU-E and BFU-E) from B-chronic lymphocytic leukemia (B-CLL).B 慢性淋巴细胞白血病(B-CLL)患者骨髓红系祖细胞(CFU-E 和 BFU-E)对重组人促红细胞生成素(rh-Epo)的反应性。
J Exp Clin Cancer Res. 1997 Jun;16(2):163-70.
5
[In vitro effects of high titers of recombinant human erythropoietin on the bone marrow erythroid progenitors in patients with aplastic anemia].
Rinsho Ketsueki. 1989 Apr;30(4):437-42.
6
Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.采用含重组人促红细胞生成素、小剂量甲泼尼龙和诺龙的联合方案成功治疗难治性贫血。
J Exp Clin Cancer Res. 2004 Mar;23(1):47-52.
7
Bone marrow failure following severe injury in humans.人类严重受伤后的骨髓衰竭。
Ann Surg. 2003 Nov;238(5):748-53. doi: 10.1097/01.sla.0000094441.38807.09.
8
Physician Education: The Erythropoietin Receptor and Signal Transduction.医师教育:促红细胞生成素受体与信号转导
Oncologist. 1996;1(5):337-339.
9
[Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
Rinsho Ketsueki. 1991 Aug;32(8):912-4.
10
Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.对于单独使用促红细胞生成素无反应的输血依赖型骨髓增生异常综合征患者,在促红细胞生成素中添加生长因子或白细胞介素-3对贫血的治疗效果有限。
Haematologica. 2001 Jan;86(1):44-51.